I disagree. This article is typical embellishment from the university that produced the research. The reality is that they're likely pre-trial stage. Even if they make it through all stages of clinical trials (historically, chances of a drug candidate doing that are 2-5%), that usually takes the better part of a decade. So the answer is "no, we're very far from curing it".
Yes. The tldr is that this is a drug that showed promise that is in the early pretrial stages. Most drugs fail before they reach the market. Even if this one doesn't, it will take a decade at least before this will be available.
